Anticipating problems, optimising design
A thorough analysis of fluids and thermodynamic behaviour at the start of the design process is crucial. By understanding how heat will flow and how fluids and gases will interact with the proposed system, the time and cost of iteration and testing can be greatly reduced.
We use our expertise to ensure appropriate device specifications and optimise heat transfer in relation to critical components – an increasingly complex challenge as consumer products and batteries become ever smaller.
Our expertise in fluids and thermodynamics empowers our medical technology clients to overcome complex challenges, including:
- Thermal problems of amplifying DNA during PCR (polymerase chain reaction)
- Blood separation to identify CTCs (circulating tumour cells) during cancer diagnosis and treatment
- Liquid biopsy for clinical diagnostics
- Extracting gas out of a liquid (e.g. extracting air out of a drug prior to injection)
- Aerosol science, including liquid nebulisers, sprays and inhalers
By taking a fresh look at traditional bulk manufacturing methods, we found a way of producing microcapsules continuously with real-time control of the process.
This new technique for creating microcapsules on demand is more efficient and cost-effective, eliminating the need to produce a full batch. This provides huge flexibility and personalisation opportunities for manufacturers, as well as the promise of increased process control, yield and agility.
Few technology projects we encounter are free of fluid or thermodynamic considerations. Consequently, our expertise dates back almost as far as Cambridge Consultants itself. One of the earliest examples of our success in this field is inkjet printing, from which we created numerous spin-out companies in the 1980s, including Domino and Xaar.
As computing power has increased, our ability to quickly carry out studies using advanced computer-aided engineering (CAE) has continually improved so that, today, we are able to combine our deep scientific understanding and experience in the field with cutting-edge technology and facilities.
Broad, impartial expertise
Our multidisciplinary teams bring experience in nanofluidics, microfluidics and multiphase fluidics, with particular strengths in aerosol generation at a range of temperatures. We have also made significant investments in DNA liquid aerosols and nebulisers.
As an agnostic technology partner, we provide our clients with an informed yet impartial view of all available technologies and applications.
Interested in joining us?
Tech, tools & facilities
We’re experts in applying computational fluid dynamics (CFD) simulation tools, including CFX and Fluent, to conduct finite element analysis (FEA).
Our microfluidics lab is equipped to rapidly prototype Polydimethylsiloxane (PDMS) microfluidic devices in a clean environment. We optically inspect functioning test cartridges with state-of-the-art microscopy, and measure particle size distributions with a Spraytec laser diffraction system.
We can help you
achieve the seemingly impossible
We helped Chiesi Farmaceutici create a novel, next-generation dry powder inhaler (DPI) to compete with the market leaders throughout Europe.
Vinfusion is a personalised wine blending system that allows the user to design their perfect wine. Vinfusion also makes wine recommendations based on the user’s tastes while collecting valuable market intelligence for the vendor.
Developing a high-performance, zero-maintenance subsea water cut sensor
The extremely fast polymerase chain reaction (PCR) device we developed has sped up the diagnosis of patients and helped our client maintain its leading position in the molecular diagnostics market.
News & insights
Cambridge Consultants today unveils Veloci-Vent, a sophisticated emergency ventilator designed and built at the request of the UK Government for use in the treatment of COVID-19.
Leading medical device development companies have been asked by the UK Government to develop and manufacture ventilators at massive speed.
The rapid, at home COVID-19 antigen test from digital diagnostics company Ellume features core technology from Cambridge Consultants. Read how this FDA approved test is set to be a game-changer in the global pandemic.
- Digital health
- Fluids & thermodynamics
Despite intense media focus and impassioned societal debate, meaningful progress on climate change is a glacially slow business - this is particularly true in the medical device sector. Dan Cowen explores how radical technological innovation is the way forward.
- Fluids & thermodynamics
- Physical sciences
- Product realisation
The Society for Laboratory Automation and Screening (SLAS) conference is the premier conference and industry exhibition dedicated to uniting a global community focused on advancing scientific discovery and technology. The three-day conference and exhibition consists of a program of virtual presentations with live Q&A sessions and an engaging gallery of E-posters.